Sriram Gubbi
- Infectious Diseases top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Molecular Biology
- Physiology top 10%
- Neurology top 5%
- Co-authors
- Ranganath MuniyappaNir BarzilaiAmeya KulkarniJoanna Kłubo-GwieździńskaChristian A. KochRashika BansalFady Hannah‐ShmouniDerek M. Huffman
- Topics
- Thyroid Cancer Diagnosis and Treatment (14 papers)Hormonal Regulation and Hypertension (8 papers)Pituitary Gland Disorders and Treatments (7 papers)
- Partner nations
- United StatesCanadaGreece
In The Last Decade
Sriram Gubbi
40 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Infectious Diseases 521
- Endocrinology, Diabetes and Metabolism 467
- Molecular Biology 450
- Physiology 345
- Neurology 333
Countries citing papers authored by Sriram Gubbi
This map shows the geographic impact of Sriram Gubbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sriram Gubbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sriram Gubbi more than expected).
Fields of papers citing papers by Sriram Gubbi
This network shows the impact of papers produced by Sriram Gubbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sriram Gubbi. The network helps show where Sriram Gubbi may publish in the future.
Co-authorship network of co-authors of Sriram Gubbi
This figure shows the co-authorship network connecting the top 25 collaborators of Sriram Gubbi. A scholar is included among the top collaborators of Sriram Gubbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sriram Gubbi. Sriram Gubbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 17 | |
| 10 | 4 | |
| 11 | 5 | |
| 12 | 32 | |
| 13 | 8 | |
| 14 | 50 | |
| 15 | Benefits of Metformin in Attenuating the Hallmarks of Agingbreakdown → | 496 |
| 16 | 35 | |
| 17 | 68 | |
| 18 | 3 | |
| 19 | 25 | |
| 20 | 1 |
About Sriram Gubbi
Sriram Gubbi is a scholar working on Endocrinology, Diabetes and Metabolism, Health Informatics and Neurology, having authored 46 papers that have together received 2.0k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (14 papers), Hormonal Regulation and Hypertension (8 papers) and Pituitary Gland Disorders and Treatments (7 papers). The work is most often cited by research in Aging (113 citations), Infectious Diseases (521 citations) and Endocrinology, Diabetes and Metabolism (467 citations). Sriram Gubbi has collaborated with scholars based in United States, Canada and Greece. Frequent co-authors include Ranganath Muniyappa, Nir Barzilai, Ameya Kulkarni, Joanna Kłubo-Gwieździńska, Christian A. Koch, Rashika Bansal, Fady Hannah‐Shmouni, Derek M. Huffman, Sofiya Milman and Joseph G. Verbalis. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Cell Metabolism and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.